Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?

Background The continuation of preventive drugs among older patients with advanced cancer has come under scrutiny because these drugs are unlikely to achieve their clinical benefit during the patients’ remaining lifespan. Methods A nationwide cohort study of older adults (those aged ≥65 years) with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2019-07, Vol.125 (13), p.2309-2317
Hauptverfasser:	Morin, Lucas, Todd, Adam, Barclay, Stephen, Wastesson, Jonas W., Fastbom, Johan, Johnell, Kristina
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adults Aged Aged, 80 and over Anticoagulants Antihypertensives Cancer Confidence intervals Death deprescribing Deprescriptions drug prescribing Drugs End of life Female Follow-Up Studies Gynecological cancer Humans Life span Lung cancer Male Middle Aged Mortality Neoplasms - prevention & control Older people Oncology palliative care Pancreatic cancer Platelet aggregation Prognosis Retrospective Studies Solid tumors Statins Survival Rate Terminal Care - standards Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!